(Q39860463)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

P Schache

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

E Gürlevik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

N Strüver

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

N Malek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

L Zender

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

M Manns

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

T Wirth

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

F Kühnel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

S Kubicka

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

16 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

849-861

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369968%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2009.39

26 January 2020

exact match

0 references

cites work

Differential interactions between Beclin 1 and Bcl-2 family members

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

Vesicular stomatitis virus as an oncolytic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Defective translational control facilitates vesicular stomatitis virus oncolysis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

VSV-tumor selective replication and protein translation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Role of matrix protein in cytopathogenesis of vesicular stomatitis virus.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Multiple vesiculoviral matrix proteins inhibit both nuclear export and import

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Role of nucleoporin induction in releasing an mRNA nuclear export block

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Inhibition of host and viral translation during vesicular stomatitis virus infection. eIF2 is responsible for the inhibition of viral but not host translation.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

The Bcl-2 family: roles in cell survival and oncogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Unique biology of Mcl-1: therapeutic opportunities in cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Characterisation of Mcl-1 cleavage during apoptosis of haematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Early activation of the mitochondrial apoptotic pathway in Vesicular Stomatitis virus-infected cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, Fas, and Daxx

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Autophagy-dependent viral recognition by plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Bax-dependent mitochondrial membrane permeabilization enhances IRF3-mediated innate immune response during VSV infection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021

Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.39

7 January 2021